12:00 AM
Dec 10, 2012
 |  BC Week In Review  |  Company News  |  Other News

J&J infectious news

Johnson & Johnson's Janssen pharmaceutical companies said they do not intend to enforce their patents covering HIV drug Prezista darunavir against medically acceptable generic...

Read the full 109 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >